COMMUNIQUÉS West-GlobeNewswire

Novo Nordisk A/S: Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function

19/09/2024 - 21:10

Wegovy ® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function Wegovy ® (semaglutide 2.4 mg) is the first obesity medication to [...]

Evoke Pharma Reaffirms Its Commitment to Patients with Gastroparesis Amid Industry Developments

19/09/2024 - 20:20

Gimoti remains the sole proprietary FDA approved treatment for symptoms of diabetic gastroparesis SOLANA BEACH, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical [...]

Bright Green Corporation Provides an Update, Reinforces Commitment to Shareholders, and Focuses on Growth and Strategic Partnerships

19/09/2024 - 19:56

GRANTS, NEW MEXICO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or the “Company”), today announced that trading of its shares have been suspended from the Nasdaq Stock [...]

Business Collaborative for Brain Health Partners with HERO to Launch the Brain Health Best Practice Score for Employers

19/09/2024 - 19:30

New educational tool will help companies assess how well their health and well-being programs support their workforce’s brain health, a critical factor in employees’ overall health, performance and productivity NEW YORK [...]

Oculis and EURETINA Announce the Winner of the Inaugural Ramin Tadayoni Award

19/09/2024 - 19:00

ZUG, Switzerland, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, in collaboration with EURETINA [...]

Innovative Cellular Therapeutics Announces the Publication of Groundbreaking GCC19CART™ Study to Treat mCRC in JAMA Oncology

19/09/2024 - 18:09

ROCKVILLE, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics, Inc. (ICT), a clinical-stage biotechnology company developing a comprehensive portfolio of chimeric antigen receptor (CAR) T cell [...]

CARBIOS and SLEEVER® partner up to co-develop and bring to market first Home Compost biodegradable shrinksleeve labels

19/09/2024 - 18:00

Clermont-Ferrand and Morangis (France), Thursday 19 September 2024 (6pm CEST). CARBIOS , (Euronext Growth Paris : ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the [...]

CARBIOS et SLEEVER® nouent un partenariat de co-développement pour la mise sur le marché des premières étiquettes-sleeves biodégradables Home Compost

19/09/2024 - 18:00

Clermont-Ferrand et Morangis (France), le jeudi 19 octobre 2024 (18h00 CEST) : CARBIOS (Euronext Growth Paris : ALCRB), pionnière dans le développement et l'industrialisation de technologies biologiques pour réinventer [...]

Precede Biosciences Presents Data on Liquid Biopsy Comprehensive Epigenomic Profiling of MS Patients at ECTRIMS 2024

19/09/2024 - 16:50

Data underscore the potential to leverage comprehensive epigenomic profiling from a simple blood test to explore central nervous system disease biology BOSTON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Precede Biosciences, a [...]

Thought Leadership & Innovation Foundation Announces Partnership with Paradigm to Support Limb Loss and Preservation Registry

19/09/2024 - 16:20

MCLEAN, Va., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Thought Leadership & Innovation Foundation (TLI) , a not-for-profit organization that works at the nexus of science, technology and public health, today announces a [...]

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 août 2024

19/09/2024 - 16:04

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 août 2024 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, les [...]

Rejuveron Life Sciences AG Rebrands as Centenara Labs AG and Provides Latest Clinical Updates

19/09/2024 - 16:00

Shareholders approve name change and rebranding to Centenara Labs AG (“Centenara”) Rebrand positions business for strategic initiatives designed to support development of therapies for regenerative medicine and age- [...]

Bright Minds Biosciences to Host Investor & Analyst KOL Event on September 25th

19/09/2024 - 16:00

Bright Minds Biosciences announced the initiation of Phase 2 clinical trial of BMB-101 in a group of drug-resistant epilepsies and will discuss the details of the BREAKTHROUGH clinical trial on September 25th. The event [...]

IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology

19/09/2024 - 16:00

Nashville, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC Holdings” or the “Company”), a leader in innovative healthcare solutions, proudly announces the launch of an entirely new [...]

Leap Distributors Acquires Leap Surgical and DUB Enterprises: Partnership Positions Company for Continued Growth

19/09/2024 - 15:47

DALLAS, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Leap Distributors has acquired Leap Surgical and DUB Enterprises, two privately owned and nationally recognized medical device firms. Effective immediately, the three companies [...]

Bavarian Nordic Receives EMA Approval of Mpox Vaccine for Adolescents

19/09/2024 - 15:45

MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA Represents the second EMA approval of an MVA-BN-based vaccine for a younger population COPENHAGEN, [...]

Immix Biopharma Announces Dr. Raymond Comenzo, Internationally Recognized AL Amyloidosis Expert, Director of the Myeloma and Amyloid Program at Tufts Medical Center, Joins Scientific Advisory Board

19/09/2024 - 15:31

Dr. Comenzo was the senior author of the landmark Andromeda trial results published in the New England Journal of Medicine in 2021, resulting in the first FDA-approved therapy for AL amyloidosis Dr. Comenzo was the lead [...]

FibroBiologics Engages Southern Star Research as CRO in Australia

19/09/2024 - 15:31

Southern Star Research will provide CRO services for FibroBiologics in Australia HOUSTON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company [...]

Labviva Introduces Real Time Inventory Management System for Life Sciences Purchasing

19/09/2024 - 15:00

Enterprise procure-to-payment provider advances AI automation for inventory and purchase intelligence BOSTON, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Labviva , the leading AI procurement platform for life sciences, today [...]